Old Web
English
Sign In
Acemap
>
authorDetail
>
Loic Ysebeart
Loic Ysebeart
Pathology
Gene expression profiling
Diffuse large B-cell lymphoma
Angiogenesis
Tumor microenvironment
2
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Association of low expression of VEGF121 soluble isoform with prognostic impact and survival in patients with activated B-cell-like (ABC-like) diffuse large B-cell lymphoma (DLBCL) from the CORAL trial.
2017
Journal of Clinical Oncology
Catherine Thieblemont
Nicolas Mounier
Samia Mourah
Rémi Houlgatte
Edouard Hirchaud
Wendy Cuccuini
Loic Ysebeart
Dominique Bron
Philippe Gaulard
Christian Gisselbrecht
Josette Brière
Show All
Source
Cite
Save
Citations (0)
A phase III, randomized, controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).
2013
Journal of Clinical Oncology
Ian W. Flinn
Eva Kimby
Finbarr E. Cotter
Francis J. Giles
Ann Janssens
Elisa Jacobsen Pulczynski
Loic Ysebeart
Andrzej Pluta
José García Marco
Kerry Taylor
Carolyn Owen
David Michael Johnson
María Aiello
Roger Dansey
Ronald L. Dubowy
Jeffrey A. Jones
Show All
Source
Cite
Save
Citations (20)
1